| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/06/1999 | EP0832900A4 Peptide and method of obtaining it |
| 10/06/1999 | EP0722326A4 Highly sulfated maltooligosaccharides with heparin-like properties |
| 10/06/1999 | EP0660705B1 Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
| 10/06/1999 | EP0597018B1 Glycosidation reaction |
| 10/06/1999 | EP0584068B1 Method and composition for ameliorating the adverse effects of aging |
| 10/06/1999 | CN1230998A Three component chimeric antisense oligonucleotides |
| 10/06/1999 | CN1230962A 3-substituted pyrido [4',3' : 4, 5] thieno [2,3-D] pyrimidine derivatives, their preparation and their use |
| 10/06/1999 | CN1230960A Intermediates for preparation of duocarmycin SA and derivatives thereof, and process for production of intermdiates |
| 10/06/1999 | CN1230959A N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics |
| 10/06/1999 | CN1230956A Method of producing polyphenol-containing compositions |
| 10/06/1999 | CN1230955A Dihydrobenzopyran and related compounds useful as anti-inflammatory agents |
| 10/06/1999 | CN1230948A Pyranoindole and carbazole inhibitors of COX-2 |
| 10/06/1999 | CN1230894A Pharmaceutical composition containing a 5HT2C antagonist and A D2 antagonist |
| 10/06/1999 | CN1230891A Lectin compositions and uses thereof |
| 10/06/1999 | CN1230890A Injectable formulations of avermectins and milbemycins |
| 10/06/1999 | CN1230889A Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals |
| 10/06/1999 | CN1230888A Oral contraceptive |
| 10/06/1999 | CN1230887A Reducing toxic effects of carboplatin using dithioethers |
| 10/06/1999 | CN1230886A Combination therapy for treatment of psychoses |
| 10/06/1999 | CN1230885A Use of benzopyranols to treat neurological disorders |
| 10/06/1999 | CN1230884A Thiol sulfone metalloprotease inhibitors |
| 10/06/1999 | CN1230883A Coated particle formulation |
| 10/06/1999 | CN1230882A Method and composition for rewetting contact lenses and relieving eye dryness |
| 10/06/1999 | CN1230875A Flavonol containing food supplements |
| 10/06/1999 | CN1230549A Escape mutant of surface antigen of hepatitis B virus |
| 10/06/1999 | CN1230542A Sidechain-bearing taxanes |
| 10/06/1999 | CN1230429A Medicine for trachitis and its preparation |
| 10/06/1999 | CN1230415A Combined Chinese and Western medicine for treating nevus and its preparation |
| 10/06/1999 | CN1230410A Cancer-curing mixed antisense medicine |
| 10/06/1999 | CN1230409A Phosphonocarboxylate compounds and pharmaceutical compositions containing the same |
| 10/06/1999 | CN1230408A Compound alkaloid terpene hydrochloride analgesic preparation |
| 10/06/1999 | CN1230407A Method and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia |
| 10/06/1999 | CN1230406A Application of benzoic benzylamine amide as bitter agent |
| 10/06/1999 | CN1230401A Compound non-opium drug abstaining spray |
| 10/06/1999 | CN1045472C Technology for extracting polyose protein from mushroom using enzyme process and producing polyose protein capsule |
| 10/06/1999 | CN1045443C Novel purine derivatives and pharmaceutically acceptable salts thereof |
| 10/06/1999 | CN1045442C Levo- and dextro- chloroscouriline (tetrahydroprotoberberines) and preparation and application thereof |
| 10/06/1999 | CN1045441C Antifungal agents, processes for the preparation thereof, and intermediates |
| 10/06/1999 | CN1045440C Process for preparing medicinal preparation containing beta-form thiamine hydrochloride crystals |
| 10/06/1999 | CN1045438C 4H carbazoleone Mannich base and its synthesizing method and application |
| 10/06/1999 | CN1045435C Naphthalene derivative, preparation thereof and middle agent syntherised of same |
| 10/06/1999 | CN1045431C 15-deoxyspergualin analogs, their preparation method, compositions, intermediate and use in preparation of medicine thereof |
| 10/06/1999 | CN1045391C Oral delivery system |
| 10/06/1999 | CN1045383C Medicine composition for curing senile cataract |
| 10/06/1999 | CN1045382C Chloramphenicol eye drop contg. sodium hyaluronic acid and its preparation |
| 10/06/1999 | CN1045362C Microbicide compositions containing iodide |
| 10/05/1999 | US5962712 Therapy of disease and stress |
| 10/05/1999 | US5962707 19-nor-vitamin D3 compounds with calcemic activity |
| 10/05/1999 | US5962701 Heat and oxidation resistance; photostability |
| 10/05/1999 | US5962698 Plasminogen activator inhibitor |
| 10/05/1999 | US5962695 Aromatic amidine derivatives and salts thereof |
| 10/05/1999 | US5962693 Catalytic hydrogenation |
| 10/05/1999 | US5962686 Fungicides |
| 10/05/1999 | US5962682 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 10/05/1999 | US5962669 Nucleic acid encoding prion protein variant |
| 10/05/1999 | US5962666 Polynucleotide or its complement which codes for enzyme involved in bacterial protein synthesis; for diagnosis and treatment of chlamydia infections such as urogenital disorders and vision defects; bactericides |
| 10/05/1999 | US5962663 Producing biopolymer with high molecular weight and low viscosity by repeatedly contacting fresh crustacean shells with aqueous mineral acid and alkali metal hydroxide solutions |
| 10/05/1999 | US5962661 Seco compounds from the class of tylosins |
| 10/05/1999 | US5962660 Compound which suppresses selectin-mediated cellular adhesion; for stable antiinflammatory agents with better bioavailability and greater activity which are easier to synthesize |
| 10/05/1999 | US5962659 Anthelmintic milbemycins and avermectins |
| 10/05/1999 | US5962536 Injectable propofol formulations |
| 10/05/1999 | US5962535 Composition for alzheimer's disease |
| 10/05/1999 | US5962534 Regulating gene expression using retinoids with CH2 OH or related groups at the side chain terminal position |
| 10/05/1999 | US5962532 Therapeutic method with capsaicin and capsaicin analogues |
| 10/05/1999 | US5962531 5-aroylnaphthalene derivatives as anti-inflammatory agents |
| 10/05/1999 | US5962530 Neuropeptide y antagonist |
| 10/05/1999 | US5962529 Metalloproteinase inhibitors |
| 10/05/1999 | US5962528 Administering uretha |
| 10/05/1999 | US5962527 Method and composition for treating cancers |
| 10/05/1999 | US5962526 Pharmaceutical compositions containing hydroxycarboxylic acids and/or ketocarboxylic acids and methods of using same |
| 10/05/1999 | US5962525 6,7-disubstituted-2-aminotetralines active as immunomodulators and pharmaceutical compositions containing same |
| 10/05/1999 | US5962524 For skins |
| 10/05/1999 | US5962523 Cancer patients undergoing chemotherapy, radiation |
| 10/05/1999 | US5962522 Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds |
| 10/05/1999 | US5962521 Prostate glands disorders |
| 10/05/1999 | US5962518 Fungicide |
| 10/05/1999 | US5962517 Pharmaceutical compositions and methods for treating acne |
| 10/05/1999 | US5962516 Immunosuppressive compounds and methods |
| 10/05/1999 | US5962515 Immunomodulators |
| 10/05/1999 | US5962514 Combination of 5-HT uptake inhibitor with a selective 5-HT1A antagonist |
| 10/05/1999 | US5962513 Central nervous system, psychological disorders |
| 10/05/1999 | US5962512 Oil containing 5-methoxypsoralen at a concentration of 60-100 ppm, and its use in treatment of psoriasis |
| 10/05/1999 | US5962511 Drugs for allergic and eosinophilic diseases |
| 10/05/1999 | US5962509 Dithiolylidene acetamide derivatives |
| 10/05/1999 | US5962505 Topical administering a glycopyrrolate compound |
| 10/05/1999 | US5962504 Activator of protein kinase; anticancer agent |
| 10/05/1999 | US5962503 Use of cholinesterase inhibitors in the treatment of xerostomia |
| 10/05/1999 | US5962502 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use |
| 10/05/1999 | US5962501 Headaches |
| 10/05/1999 | US5962500 Insulin sensitivity with angiotensin II receptor blocking imidazoles |
| 10/05/1999 | US5962499 Acaricidal, antiparasitic, insecticidal and anthelmintic agents |
| 10/05/1999 | US5962497 A 3,4-diphenyl substituted chroman compound |
| 10/05/1999 | US5962496 Central nervous system disorders |
| 10/05/1999 | US5962495 Estrogen sensitive diseases; breast cancer; prostate tumors |
| 10/05/1999 | US5962494 Methods for treating behavioral and other disorders using optically pure R(+) ondansetron |
| 10/05/1999 | US5962493 Hypolipemic agents; anticholesterol agents |
| 10/05/1999 | US5962492 Antiasthma agents; antiinflammatory agents |
| 10/05/1999 | US5962490 Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 10/05/1999 | US5962489 Fungicides |
| 10/05/1999 | US5962488 Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives |